Skip to main content
World Journal of Gastroenterology logoLink to World Journal of Gastroenterology
letter
. 2007 Apr 28;13(16):2390–2391. doi: 10.3748/wjg.v13.i16.2390

Inactivation of digestive proteases: Another aspect of gut bacteria that should be taken into more consideration

Xiaofa Qin 1
PMCID: PMC4147156  PMID: 17511046

TO THE EDITOR

Protein has been one of the main components of our diet, and a large amount of digestive proteases is released into the gut for their digestion. However, these proteases can digest not only the proteins we eat, but also the structural proteins built in our body. To protect against this damage, our body has taken a variety of measures. For instance, these digestive proteases are stored and secreted in the form of zymogen and only activated in gut lumen[1]. These luminal digestive proteases are further prevented from direct contact with epithelial cells by the mucus layer that is incessantly secreted by the goblet cells in gut mucosa[2]. In addition, large quantities of protease inhibitors are produced in the body to inactivate the digestive proteases that have entered the body[3]. Despite these measures, the protection seems still weak and can be easily compromised. For instance, studies have well shown that pancreatic proteases play a critical role in mucosal damage induced by hemorrhagic and endotoxic shock[4,5], ischemia-reperfusion[6,7], stress[5], acute radiation[8], or agents such as indomethacin[9], ibuprofen[10], or oleic acid[11]. Gut damage can be greatly alleviated by inhibition of these digestive proteases[4,6], ligation of the pancreatic duct[12,13], or pancreatectomy[14]. Conversely, intraluminal injection of trypsin aggravates the lesion of the mucosa[15]. Therefore, a prompt inactivation of these digestive proteases may play an important protective role against this digestive damage. Under conventional condition, digestive proteases are effectively inactivated at the lower intestine, which depends on certain kinds of bacteria in the gut[16,17]. An inhibition of gut bacteria by factors such as saccharin, and the resulting impairment in protease inactivation and over-digestion of the mucosa may play a causative role in IBD[18,19]. It may also contribute to the increased intestinal permeability and the development of many other autoimmune and allergic diseases such as multiple sclerosis, typeIdiabetes, asthma, and atopic dermatitis, which seem to be associated with improved hygiene condition and reduced bacteria exposure[20]. Therefore, besides the immune regulatory and toxic effect of gut bacteria on the host, the role of gut bacteria in protease inactivation would be another aspect that should be taken into consideration.

Footnotes

S- Editor Liu Y L- Editor Wang XL E- Editor Lu W

References

  • 1.Ruthenbürger M, Mayerle J, Lerch MM. Cell biology of pancreatic proteases. Endocrinol Metab Clin North Am. 2006;35:313–331, ix. doi: 10.1016/j.ecl.2006.02.007. [DOI] [PubMed] [Google Scholar]
  • 2.Atuma C, Strugala V, Allen A, Holm L. The adherent gastrointestinal mucus gel layer: thickness and physical state in vivo. Am J Physiol Gastrointest Liver Physiol. 2001;280:G922–G929. doi: 10.1152/ajpgi.2001.280.5.G922. [DOI] [PubMed] [Google Scholar]
  • 3.Travis J, Salvesen GS. Human plasma proteinase inhibitors. Annu Rev Biochem. 1983;52:655–709. doi: 10.1146/annurev.bi.52.070183.003255. [DOI] [PubMed] [Google Scholar]
  • 4.Acosta JA, Hoyt DB, Schmid-Schönbein GW, Hugli TE, Anjaria DJ, Frankel DA, Coimbra R. Intraluminal pancreatic serine protease activity, mucosal permeability, and shock: a review. Shock. 2006;26:3–9. doi: 10.1097/01.shk.0000209557.31457.ae. [DOI] [PubMed] [Google Scholar]
  • 5.Bounous G. "Tryptic enteritis": its role in the pathogenesis of stress ulcer and shock. Can J Surg. 1969;12:397–409. [PubMed] [Google Scholar]
  • 6.Bounous G, Menard D, De Medicis E. Role of pancreatic proteases in the pathogenesis of ischemic enteropathy. Gastroenterology. 1977;73:102–108. [PubMed] [Google Scholar]
  • 7.Bounous G. Pancreatic proteases and oxygen-derived free radicals in acute ischemic enteropathy. Surgery. 1986;99:92–94. [PubMed] [Google Scholar]
  • 8.Delaney JP, Bonsack M. Acute radiation enteritis in rats: bile salts and trypsin. Surgery. 1992;112:587–592. [PubMed] [Google Scholar]
  • 9.Kimura RE, Arango V, Lloyd-Still J. Indomethacin and pancreatic enzymes synergistically damage intestine of rats. Dig Dis Sci. 1998;43:2322–2332. doi: 10.1023/a:1026691227845. [DOI] [PubMed] [Google Scholar]
  • 10.Kimura RE, Dy SA, Uhing MR, Beno DW, Jiyamapa VA, Lloyd-Still JD. The effects of high-dose ibuprofen and pancreatic enzymes on the intestine of the rat. J Pediatr Gastroenterol Nutr. 1999;29:178–183. doi: 10.1097/00005176-199908000-00014. [DOI] [PubMed] [Google Scholar]
  • 11.Lloyd-Still JD, Uhing MR, Arango V, Fusaro A, Kimura RE. The effect of intestinal permeability on pancreatic enzyme-induced enteropathy in the rat. J Pediatr Gastroenterol Nutr. 1998;26:489–495. doi: 10.1097/00005176-199805000-00001. [DOI] [PubMed] [Google Scholar]
  • 12.Soma LR, Neufeld GR, Dodd DC, Marshall BE. Pulmonary function in hemorrhagic shock: the effect of pancreatic ligation and blood filtration. Ann Surg. 1974;179:395–402. doi: 10.1097/00000658-197404000-00002. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 13.De Koos EB, Gibson WJ, Bounous G, Hampson LG. The influence of pancreatic duct ligation on the course of E. coli endotoxin shock in the dog. Can J Surg. 1966;9:227–230. [PubMed] [Google Scholar]
  • 14.Smith EE, Crowell JW, Moran CJ, Smith RA. Intestinal fluid loss in dogs during irreversible hemorrhagic shock. Surg Gynecol Obstet. 1967;125:45–48. [PubMed] [Google Scholar]
  • 15.Bounous G, Hampson LG, Gurd FN. Cellular Nucleotides in Hemorrhagic Shock: Relationship of Intestinal Metabolic Changes to Hemorrhagic Enteritis and the Barrier Function of Intestinal Mucosa. Ann Surg. 1964;160:650–668. doi: 10.1097/00000658-196410000-00010. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 16.Norin KE, Gustafsson BE, Midtvedt T. Strain differences in faecal tryptic activity of germ-free and conventional rats. Lab Anim. 1986;20:67–69. doi: 10.1258/002367786781062188. [DOI] [PubMed] [Google Scholar]
  • 17.Midtvedt T, Carlstedt-Duke B, Höverstad T, Midtvedt AC, Norin KE, Saxerholt H. Establishment of a biochemically active intestinal ecosystem in ex-germfree rats. Appl Environ Microbiol. 1987;53:2866–2871. doi: 10.1128/aem.53.12.2866-2871.1987. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 18.Qin XF. Impaired inactivation of digestive proteases by deconjugated bilirubin: the possible mechanism for inflammatory bowel disease. Med Hypotheses. 2002;59:159–163. doi: 10.1016/s0306-9877(02)00243-8. [DOI] [PubMed] [Google Scholar]
  • 19.Qin X. Is the incidence of inflammatory bowel disease in the developed countries increasing again? Is that surprising? Inflamm Bowel Dis. 2007;13:804–805. doi: 10.1002/ibd.20083. [DOI] [PubMed] [Google Scholar]
  • 20.Qin X. What caused the increase of autoimmune and allergic diseases: a decreased or an increased exposure to luminal microbial components? World. J Gastroenterol. 2007;13:1306–1307. doi: 10.3748/wjg.v13.i8.1306. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from World Journal of Gastroenterology : WJG are provided here courtesy of Baishideng Publishing Group Inc

RESOURCES